[go: up one dir, main page]

WO2009083520A3 - Compositions orales liquides de florfenicol diluables dans l'eau de boisson - Google Patents

Compositions orales liquides de florfenicol diluables dans l'eau de boisson Download PDF

Info

Publication number
WO2009083520A3
WO2009083520A3 PCT/EP2008/068127 EP2008068127W WO2009083520A3 WO 2009083520 A3 WO2009083520 A3 WO 2009083520A3 EP 2008068127 W EP2008068127 W EP 2008068127W WO 2009083520 A3 WO2009083520 A3 WO 2009083520A3
Authority
WO
WIPO (PCT)
Prior art keywords
diluted
drinking water
liquid oral
florfenicol
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2008/068127
Other languages
English (en)
Other versions
WO2009083520A2 (fr
Inventor
Sandrine Lacoste
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ceva Sante Animale SA
Original Assignee
Ceva Sante Animale SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale SA filed Critical Ceva Sante Animale SA
Publication of WO2009083520A2 publication Critical patent/WO2009083520A2/fr
Publication of WO2009083520A3 publication Critical patent/WO2009083520A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention a pour objet une composition orale liquide à forte concentration en florfénicol, diluable et miscible dans l'eau de boisson ayant une stabilité améliorée au cours du temps, ainsi qu'une composition buvable de florfénicol destinée au traitement des infections respiratoires et/ou digestives des animaux non humains.
PCT/EP2008/068127 2007-12-21 2008-12-21 Compositions orales liquides de florfenicol diluables dans l'eau de boisson Ceased WO2009083520A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0709197A FR2925335B1 (fr) 2007-12-21 2007-12-21 Compositions orales liquides de florfenicol diluables dans l'eau de boisson
FR07/09197 2007-12-21

Publications (2)

Publication Number Publication Date
WO2009083520A2 WO2009083520A2 (fr) 2009-07-09
WO2009083520A3 true WO2009083520A3 (fr) 2009-12-03

Family

ID=39764250

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/068127 Ceased WO2009083520A2 (fr) 2007-12-21 2008-12-21 Compositions orales liquides de florfenicol diluables dans l'eau de boisson

Country Status (2)

Country Link
FR (1) FR2925335B1 (fr)
WO (1) WO2009083520A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1002023A2 (pt) * 2010-03-01 2011-10-25 Nanocore Biotecnologia S A forma farmacêutica sólida de dissolução rápida para tratamento de infecções bacterianas
CN114010594B (zh) * 2021-09-30 2023-01-03 枣庄学院 一种氟苯尼考自微乳

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004014341A1 (fr) * 2002-08-13 2004-02-19 Dae Han New Pharm Co., Ltd. Composition pharmaceutique pour administration orale contenant du florfenicol en tant que principe actif
WO2004014340A1 (fr) * 2002-08-13 2004-02-19 Dae Han New Pharm Co., Ltd. Composition injectable comprenant du florfenicol comme principe actif
KR20050102309A (ko) * 2004-04-21 2005-10-26 대한뉴팜(주) 플로르페니콜을 유효성분으로 하는 주사제 조성물
WO2006067138A2 (fr) * 2004-12-21 2006-06-29 Intervet International B.V. Composition veterinaire injectable
KR20060105826A (ko) * 2005-04-04 2006-10-11 주식회사 고려비엔피 동물약품용 약제학적 조성물
CN101152169A (zh) * 2007-09-06 2008-04-02 杨水新 一种氟苯尼考微乳的制备方法
WO2008085310A2 (fr) * 2006-12-19 2008-07-17 Schering-Plough Ltd. Formulations effervescentes de florfénicol à ajouter dans les systèmes d'eau potable

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004014341A1 (fr) * 2002-08-13 2004-02-19 Dae Han New Pharm Co., Ltd. Composition pharmaceutique pour administration orale contenant du florfenicol en tant que principe actif
WO2004014340A1 (fr) * 2002-08-13 2004-02-19 Dae Han New Pharm Co., Ltd. Composition injectable comprenant du florfenicol comme principe actif
KR20050102309A (ko) * 2004-04-21 2005-10-26 대한뉴팜(주) 플로르페니콜을 유효성분으로 하는 주사제 조성물
WO2006067138A2 (fr) * 2004-12-21 2006-06-29 Intervet International B.V. Composition veterinaire injectable
KR20060105826A (ko) * 2005-04-04 2006-10-11 주식회사 고려비엔피 동물약품용 약제학적 조성물
WO2008085310A2 (fr) * 2006-12-19 2008-07-17 Schering-Plough Ltd. Formulations effervescentes de florfénicol à ajouter dans les systèmes d'eau potable
CN101152169A (zh) * 2007-09-06 2008-04-02 杨水新 一种氟苯尼考微乳的制备方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002497292, retrieved from STN Database accession no. 146:190 500 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002497293, retrieved from STN Database accession no. 145; 299 746 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002549333, retrieved from STN Database accession no. 148: 456513 *

Also Published As

Publication number Publication date
FR2925335B1 (fr) 2010-03-19
WO2009083520A2 (fr) 2009-07-09
FR2925335A1 (fr) 2009-06-26

Similar Documents

Publication Publication Date Title
FR22C1027I2 (fr) Utilisation de formulations stabilisant et inhibant la précipitation de compositions immunogènes
WO2009070740A3 (fr) Nouveaux composés et nouvelles compositions et leurs procédés d'utilisation
WO2011159839A3 (fr) Composés de thioacétate, compositions et procédés d'utilisation
WO2011159840A3 (fr) Phénylthioacétates, compositions et procédés d'application
MX2009003741A (es) Composiciones liquidas de calcogenuro y metodos para fabricar y utilizar las mismas.
IL253038A0 (en) Preparations and methods for the treatment or prevention of infections. my voice
CL2008000592A1 (es) Compuestos derivados de pirrol sustituido, supresores de la secrecion de acidos; composicion farmaceutica; y uso en el tratamiento o profilaxis en enfermedades tales como ulcera peptica, gastritis, esofagitis, entre otras.
WO2007077561A3 (fr) Compositions et procédés permettant d'améliorer le captage in-vivo d'agents pharmaceutiques
IL202386A0 (en) Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
EP2476461A3 (fr) Formulations pour le traitement du cancer
DK3486320T3 (da) Raav-guanylatcyklase-sammensætninger og fremgangsmåder til behandling af lebers kongenitte amaurose-1 (lca1)
WO2009124871A3 (fr) Composition ayant une activité biocide pour les préparations aqueuses
MY162146A (en) Pharmaceutical composition
PT2119477T (pt) Composição para tratamento de xerostomia ou boca seca
WO2009100277A3 (fr) Compositions et dispositifs
BR112015008849A2 (pt) composições estáveis contendo perácido
WO2010054286A3 (fr) Composés d'hydroxyphénylamine substitués
EP1969115A4 (fr) Compositions nettoyantes, non corrosives et polyvalentes, et leurs procedes d'utilisation
WO2008132021A3 (fr) Mélanges fongicides
UA91848C2 (ru) Применение соединений диосметина в лечении и предотвращении тромботическим патологиям
BRPI0822079A2 (pt) Método, fluido de tratamento ácido, e, composição
ZA200905126B (en) Use of compounds of formula (i) and/or (II) for the preservation of human or animal bodies, and compositions containing the same
WO2009083520A3 (fr) Compositions orales liquides de florfenicol diluables dans l'eau de boisson
FR2915386B1 (fr) Utilisation d'un extrait aqueux de pepins de raisin en association avec au moins un sel de fluor contre la formation ou l'accumulation du biofilm dentaire et les compositions comprenant cette association
EP2445873A4 (fr) Inhibiteurs de la protéase, compositions les comprenant et procédés d'utilisation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08868195

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08868195

Country of ref document: EP

Kind code of ref document: A2